Sponsored

DecisionDx®-Melanoma is designed to identify cutaneous melanoma patients who can safely forgo sentinel lymph node biopsy without experiencing early recurrence

June 18th 2025

Sponsored content by Castle Biosciences, Inc. Dr. Guenther has not been compensated in connection with this article; Dr. Guenther receives compensation for his participation on the Speaker’s bureau for Castle Biosciences.

For the First Time, A Nilotinib Without Fasting Restrictions

June 16th 2025

Transforming Colorectal Cancer Care: The Critical Role of Biomarker Testing in Early Detection and Disease Management

June 3rd 2025

Sponsored Content by Pfizer, Inc.

ADC Cast: ADC antigen targets: What are we aiming at?

May 22nd 2025

This is a featured episode from an educational podcast series with expert discussions on antibody drug conjugates, intended for US healthcare professionals.

Assessing the Prostate Cancer Treatment Paradigm: Understanding When to Intensify Treatment

May 22nd 2025

Sponsored Content by Astellas Pharma US, Inc. and Pfizer Inc.; Dr. Dreicer has been compensated for the development of this article.

The Risk of Recurrence in HR+/HER2- Early Breast Cancer

April 14th 2025

Author(s): Sponsored by Novartis

Protecting Patients: Counterfeit Drugs in Oncology and the Fight Against Them

April 8th 2025

Raising the Bar in the First-Line Treatment of EGFR+* mNSCLC Advanced Lung Cancer

March 31st 2025

Managing Unseen Risks: Understanding Recurrence in Early Breast Cancer With No or Limited Nodal Involvement

January 30th 2025

Finding Common Ground: Considerations for Making Treatment Decisions in R/R Follicular Lymphoma

January 27th 2025

Navigating Transitions of Care with a Bispecific Antibody in Relapsed or Refractory Multiple Myeloma

January 22nd 2025

Real-World Head-to-Head Analyses Comparing Different Treatment Options For metastatic Castration-Sensitive Prostate Cancer

January 9th 2025

Sponsored Content: Benjamin H. Lowentritt, MD, FACS reviews Real-World Head-to-Head Analyses Comparing Different Treatment Options For metastatic Castration-Sensitive Prostate Cancer

Understanding the Patient Experience in Blood Cancer Treatment

December 20th 2024

Embracing Hepatic Artery Infusion Therapy for My Patients with Colorectal Cancer Liver Metastases

December 10th 2024

Exploring a Treatment Option for a Certain Subset of Patients with Non-Metastatic Castration-Sensitive Prostate Cancer (nmCSPC)

December 10th 2024

Dr. Tessa Cigler & Dr. John Ng: A patient-centered approach to a complex cancer case

December 6th 2024

Dr. Nasser Altorki: Neoadjuvant Immunotherapy and Radiation Boosts Responses in NSCLC

December 6th 2024

Addressing Disparities in Liver Cancer Care to Improve Access to First-Line Treatment for Minority and Underserved Populations with Hepatocellular Carcinoma

November 20th 2024

The Role of Biomarkers in the Treatment of Metastatic NSCLC

October 7th 2024

New Research Shows CDK5–Cyclin B1 Regulates Mitotic Fidelity

September 9th 2024

The study alters the existing paradigm that CDK1-Cyclin B1 is the only CDK-cyclin complex essential for all stages of mitosis.